| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2010 | Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. | Hu, CM; Kaushal, S; Tran Cao, HS; Aryal, S; Sartor, M; Esener, S; Bouvet, M; Zhang, L | Molecular pharmaceutics 7(3), 914-920 | | | |
| 2007 | Hiding human thymidine kinase 1 from APC/C- mediated destruction by thymidine binding. | Ke, PY; Hu, CM; Chang, YC; Chang, ZF | FASEB JOURNAL 21(4),1276-84 | | | |
| 2015 | Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection. | Wang, F; Gao, W; Thamphiwatana, S; Luk, BT; Angsantikul, P; Zhang, Q; Hu, CM; Fang, RH; Copp, JA; Pornpattananangkul, D; Lu, W; Zhang, L | Advanced materials 27(22), 3437-3443 | | | |
| 2015 | Hydrogels: Hydrogel Retaining Toxin-Absorbing Nanosponges for Local Treatment of Methicillin-Resistant Staphylococcus aureus Infection (Adv. Mater. 22/2015). | Wang, F; Gao, W; Thamphiwatana, S; Luk, BT; Angsantikul, P; Zhang, Q; Hu, CM; Fang, RH; Copp, JA; Pornpattananangkul, D; Lu, W; Zhang, L | Advanced materials 27(22), 3342 | | | |
| 2014 | Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. | Luk, BT; Hu, CM; Fang, RH; Dehaini, D; Carpenter, C; Gao, W; Zhang, L | Nanoscale 6(5), 2730-2737 | | | |
| 2012 | Large-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactor. | Fang, RH; Chen, KN; Aryal, S; Hu, CM; Zhang, K; Zhang, L | Langmuir : the ACS journal of surfaces and colloids 28(39), 13824-13829 | | | |
| 2013 | Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. | Fang, RH; Hu, CM; Chen, KN; Luk, BT; Carpenter, CW; Gao, W; Li, S; Zhang, DE; Lu, W; Zhang, L | Nanoscale 5(19), 8884-8888 | | | |
| 2013 | Liposome-like Nanostructures for Drug Delivery. | Gao, W; Hu, CM; Fang, RH; Zhang, L | Journal of materials chemistry. B, Materials for biology and medicine 1(48), 6569-6585 | | | |
| 2013 | Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release. | Kong, SD; Sartor, M; Hu, CM; Zhang, W; Zhang, L; Jin, S | Acta biomaterialia 9(3), 5447-5452 | | | |
| 2013 | 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. | Hu, CM; Fang, RH; Luk, BT; Chen, KN; Carpenter, C; Gao, W; Zhang, K; Zhang, L | Nanoscale 5(7), 2664-2668 | | | |
| 2011 | Micromachine-enabled capture and isolation of cancer cells in complex media. | Balasubramanian, S; Kagan, D; Hu, CM; Campuzano, S; Lobo-Castanon, MJ; Lim, N; Kang, DY; Zimmerman, M; Zhang, L; Wang, J | Angewandte Chemie-International Edition 50(18), 4161-4164 | | | |
| 2007 | Mitotic control of dTTP pool: a necessity or coincidence? | Hu, CM; Chang, ZF | JOURNAL OF BIOMEDICAL SCIENCE 14(4),491-7 | | | |
| 2015 | Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. | Gao, W; Fang, RH; Thamphiwatana, S; Luk, BT; Li, J; Angsantikul, P; Zhang, Q; Hu, CM; Zhang, L | Nano letters 15(2), 1403-1409 | | | |
| 2015 | Nanoparticle biointerfacing by platelet membrane cloaking. | Hu, CM; Fang, RH; Wang, KC; Luk, BT; Thamphiwatana, S; Dehaini, D; Nguyen, P; Angsantikul, P; Wen, CH; Kroll, AV; Carpenter, C; Ramesh, M; Qu, V; Patel, SH; Zhu, J; Shi, W; Hofman, FM; Chen, TC; Gao, W; Zhang, K; Chien, S; Zhang, L | Nature 526(7571), 118-121 | | | |
| 2010 | Nanoparticle-assisted combination therapies for effective cancer treatment. | Hu, CM; Aryal, S; Zhang, L | Therapeutic delivery 1(2), 323-334 | | | |
| 2012 | Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. | Hu, CM; Zhang, L | Biochemical pharmacology 83(8), 1104-1111 | | | |
| 2013 | Nanoparticle-detained toxins for safe and effective vaccination. | Hu, CM; Fang, RH; Luk, BT; Zhang, L | Nature nanotechnology 8(12), 933-938 | | | |
| 2012 | Nanoparticles disguised as red blood cells to evade the immune system. | Fang, RH; Hu, CM; Zhang, L | Expert opinion on biological therapy 12(4), 385-389 | | | |
| 2014 | Nanotoxoid Vaccines. | Hu, CM; Zhang, L | Nano today 9(4), 401-404 | | | |
| 2015 | Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. | Hu, CM; Zhu, J; Guo, XE; Chen, W; Qiu, XL; Ngo, B; Chien, R; Wang, YV; Tsai, CY; Wu, G; Kim, Y; Lopez, R; Chamberlin, AR; Lee, EY; Lee, WH | Oncogene 34(10), 1220-30 | | | |
